As of August 28, 2026, Regen BioPharma, Inc. (RGBP) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. Regen BioPharma, Inc. has a market capitalization of $153.6K, 511.96M shares outstanding.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
⛈️
Warning
High probability of dilution event
model est. 33%
🔁 Convertible Conversion
model 60%
• Major convertible overhang: 2701% potential dilution
• Convertible risk score very high (85/100)
📉 Score Deterioration
model 10%
• Score in HIGH risk zone (65/100)
Market Data
Market Cap$153.6K
Shares Outstanding511.96M
Float461.18M
Cash$271
Debt$107.1K
Short InterestN/A
Institutional Holdings
Institutional data not yet available.
Short Interest
Short Interest9.5K
Days to Cover1.0
% of FloatN/A
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2026-06-30
xbrl
XBRL WARRANT
2024-09-30
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual RGBP Dilution Snapshot
Regen BioPharma, Inc. (RGBP) has a DilutionScore of 65/100, rated High dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for RGBP: xbrl on 2026-06-30; xbrl on 2024-09-30.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track RGBP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking RGBP — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required